Mice with T-cell targeted deletion of TβR2 or transgenic mice expressing a dominant-negative of TβR2 are unable to respond to TGF-β1 and show a phenotype characterized by systemic autoimmunity and severe colitis (11). Here, TGFB1 is linked to colitis.